Immune privilege sites require a higher threshold level of membrane Fas ligand to stimulate inflammation and tumor rejection

被引：0
|
作者：
Gregory, MS
Repp, A
Hohlbaum, A
Saff, R
Marshak-Rothstein, A
Ksander, B
机构：
[1] Schepens Eye Res Inst, Boston, MA USA
[2] Boston Univ, Sch Med, Boston, MA 02215 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1952
引用
收藏
页码：U449 / U449
页数：1
相关论文
共 18 条
  • [1] Immune privilege or inflammation? Insights into the Fas ligand enigma
    Joe O'Connell
    Aileen Houston
    Michael W. Bennett
    Gerald C. O'Sullivan
    Fergus Shanahan
    Nature Medicine, 2001, 7 : 271 - 274
  • [2] Immune privilege or inflammation? Insights into the Fas ligand enigma
    O'Connell, J
    Houston, A
    Bennett, MW
    O'Sullivan, G
    Shanahan, F
    NATURE MEDICINE, 2001, 7 (03) : 271 - 274
  • [3] Membrane Fas ligand activates innate immunity and terminates ocular immune privilege
    Gregory, MS
    Repp, AC
    Holhbaum, AM
    Saff, RR
    Marshak-Rothstein, A
    Ksander, BR
    JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2727 - 2735
  • [4] Fas ligand expression in colon cancer:A possible mechanism of tumor immune privilege
    Wei Zhang
    World Journal of Gastroenterology, 2005, (23) : 3632 - 3635
  • [5] Fas ligand expression in colon cancer: A possible mechanism of tumor immune privilege
    Zhang, Wei
    Ding, Er-Xun
    Wang, Qiang
    Zhu, Da-Qiao
    He, Jin
    Li, Yu-Li
    Wang, Yuan-He
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (23) : 3632 - 3635
  • [6] Fas ligand is a mediator of relative immune privilege in non-specialised peripheral tissue in inflammation
    Dooldeniya, MD
    Dupont, PJ
    Ambrose, LR
    Lechler, RI
    Simpson, E
    Dyson, PJ
    Warrens, AN
    IMMUNOLOGY, 2005, 116 : 44 - 44
  • [7] Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
    Houston, A
    Bennett, MW
    O'Sullivan, GC
    Shanahan, F
    O'Connell, J
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1345 - 1351
  • [8] Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
    A Houston
    M W Bennett
    G C O'Sullivan
    F Shanahan
    J O'Connell
    British Journal of Cancer, 2003, 89 : 1345 - 1351
  • [9] Innate immune privilege is regulated by differential expression of soluble and membrane-bound Fas Ligand.
    Gregory, MS
    Repp, AC
    Hohibaum, AM
    Marshak-Rothstein, A
    Ksander, BR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S523 - S523
  • [10] Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model
    Céfai, D
    Favre, L
    Wattendorf, E
    Marti, A
    Jaggi, R
    Gimmi, CD
    INTERNATIONAL JOURNAL OF CANCER, 2001, 91 (04) : 529 - 537
12